Sentences with phrase «technology use in therapy»

During this session, professionals will gain powerful evidence - based information regarding best practices for technology use in therapy and in early childhood classrooms.

Not exact matches

Editas, a startup based in Cambridge and founded in November 2013, wants to eventually use the technology to treat disease by coming up with therapies that can modify faulty disease - causing genes.

Announced a worldwide collaboration with Sangamo Therapeutics, Inc. (Sangamo) using Sangamo's zinc finger nuclease technology platform for the development of next - generation ex vivo cell therapies in oncology.

Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.

Companies are also finding that using M&A to acquire R&D capabilities is an effective way to build positions in emerging technologies such as gene therapy and biosimilars.

In a rare appearance Dr. Chandan Sen, Director, OSU Center for Regenerative Medicine & Cell - Based Therapies will explain how this breakthrough came about and how the technology is leading to other medical discoveries and how the principle can be used to generate any tissue out of skin or fat which is abundant in human bodIn a rare appearance Dr. Chandan Sen, Director, OSU Center for Regenerative Medicine & Cell - Based Therapies will explain how this breakthrough came about and how the technology is leading to other medical discoveries and how the principle can be used to generate any tissue out of skin or fat which is abundant in human bodin human body.

First, the interns will gather information about research institutions, academic researchers, and companies conducting work in adjacent research areas (e.g. cell therapy company) who are currently using technologies that are applicable to plant - based and clean meat research or food technology.

By using hormonal therapy alongside artificial insemination technologies such as intrauterine insemination (IUI) or in vitro fertilization (IVF), we are able to cast a wide net and address as many fertility factors as possible.

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

«Cultural revolution in the study of the gut microbiome: Human gut - on - a-chip technology used to co-culture gut microbiome, human intestinal cells could lead to new therapies for inflammatory bowel diseases.»

«The use of advanced technologies may allow radiation therapy to be delivered in larger doses per treatment safely and potentially translate into an overall survival difference in NSCLC patient populations while improving patient quality of life through an acceleration of treatment courses,» said Dr. Iyengar.

In a new Essay publishing 28 December in the open access journal PLOS Biology, Kristofer Wollein Waldetoft and Sam P. Brown of Georgia Institute of Technology propose that development of alternative therapies for mild infections could help slow the development and spread of antibiotic resistance, thereby preserving the drugs» effectiveness for use in severe infectionIn a new Essay publishing 28 December in the open access journal PLOS Biology, Kristofer Wollein Waldetoft and Sam P. Brown of Georgia Institute of Technology propose that development of alternative therapies for mild infections could help slow the development and spread of antibiotic resistance, thereby preserving the drugs» effectiveness for use in severe infectionin the open access journal PLOS Biology, Kristofer Wollein Waldetoft and Sam P. Brown of Georgia Institute of Technology propose that development of alternative therapies for mild infections could help slow the development and spread of antibiotic resistance, thereby preserving the drugs» effectiveness for use in severe infectionin severe infections.

«With the rise of new and unproven stem cell treatments, the NFL faces a daunting task of trying to better understand and regulate the use of these therapies in order to protect the health of its players,» said Kirstin Matthews, the Baker Institute fellow in science and technology policy and an expert on ethical and policy issues related to biomedical research and development.

The researchers, who are based at the Academy of Scientific & Innovative Research, located at the CSIR - Indian Institute of Chemical Technology, Hyderabad, India, hope that the technique can enhance regenerative therapy for conditions like chronic wounds, where harsh inflammation in the wound can kill the cells used in regenerative stem cell treatments.

A University of Colorado Cancer Center study published in the journal Oncogene used next - generation sequencing technologies to perform the most detailed DNA - based analysis to date of 25 commonly used bladder cancer cell lines, allowing researchers to match patient tumors with their closest genetic cell line match, and demonstrated genetic alterations that may make cells more or less sensitive to common therapies.

Raydiance's technology has attracted the attention of the U.S. Food and Drug Administration (FDA), which in July 2007 signed the company to a two - year cooperative research and development agreement that has allowed the FDA's Center for Devices and Radiological Health (CDRH) to evaluate the use, safety and effectiveness of Raydiance's USP laser system in a number of areas, including the ablation of corneal tissues in refractive surgery and corneal repair; the administration of light therapy for treating cancer, cardiovascular disease and diabetes; and the removal of plaque on teeth without damaging the enamel.

Technology such as this, scientists said, may have a promising future in the identification and surgical removal of malignant tumors, as well as using near - infrared light therapies that can kill remaining cancer cells, both by mild heating of them and generating reactive oxygen species that can also kill them.

The technology developed could be applied to bacteriophages with different morphologies to be used in phage therapy, in both animals and humans.

The technology is akin to a more advanced version of constraint - induced therapy in which clinicians physically tie down a patient's good arm, which forces the patient to use the injured side.

Their research has created the technology known as gene targeting, now used in virtually all areas of biomedicine — from basic research to the development of new therapies.

Whether it's developing new products that will be manufactured in America, or getting and using energy more sustainably, or improving health care with better therapies and better use of information technology, or providing better protection for our troops abroad and our citizens at home, innovation will be key to our success.

Intellia is developing human gene and cell therapies for both ex vivo and in vivo applications using CRISPR - Cas9 gene editing technology.

I - Stem, the Institute for Stem cell Therapy and Exploration of Monogenic Diseases, has signed an agreement with Swissbased healthcare company Roche to use I - Stem's technologies in discovering novel therapies to treat devastating central nervous system (CNS) diseases such as Alzheimer's, schizophrenia, depression and anxiety.

The goal of the Program in Human Gene Therapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired diTherapy is to develop gene transfer technologies and use them for hepatic gene therapy for the treatment of genetic and acquired ditherapy for the treatment of genetic and acquired diseases.

Through the collaboration, Lysogene, UMMS and AU will develop IND - supporting preclinical studies in GM1 - gangliosidosis using AAV gene therapy technology.

We seek to «Track and Treat» the cancer cells present in patients» tissues by using lineage tracing, as well as sequencing technologies, to determine the molecular mechanisms responsible for the dissemination of cancer cells to various organs, and resistance to current therapies.

Dr. Torkamani's research covers a broad range of areas centered on the use of genomic technologies to identify the genetic etiology and underlying mechanisms of human disease in order to define precision therapies for diseased individuals.

Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive database of human genotypes and phenotypes as a basis for a variety of commercialization opportunities to help solve aging related disease and human biological decline.

In collaboration with the University of Massachusetts Medical School (UMMS) and Auburn University (AU), Lysogene is developing IND - supporting preclinical studies using AAV gene therapy technology to translate the initial proof of concept into a viable drug development program to the benefit of patients in urgent neeIn collaboration with the University of Massachusetts Medical School (UMMS) and Auburn University (AU), Lysogene is developing IND - supporting preclinical studies using AAV gene therapy technology to translate the initial proof of concept into a viable drug development program to the benefit of patients in urgent neein urgent need.

The Bulte Lab has developed methods to label cells magnetically using tiny superparamagnetic iron oxide nanoparticles in order to make them visible by magnetic resonance imaging; this technology has now been introduced in the clinic for several cell therapy applications.

In patients who exhibited a positive response to TIL therapy, the researchers were able to use ddPCR technology to detect a transient peak in HPV cfDNA, a sign of tumor deatIn patients who exhibited a positive response to TIL therapy, the researchers were able to use ddPCR technology to detect a transient peak in HPV cfDNA, a sign of tumor deatin HPV cfDNA, a sign of tumor death.

The technology, demonstrated for the first time in mice, one day may be used to treat pain, depression, epilepsy and other neurological disorders in people by targeting therapies to specific brain circuits.

11/19/2007 New Technology to Treat Breast Cancer Shows Promise in Early Application Physicians at the Rebecca and John Moores UCSD Cancer Center will present the initial outcomes of their use of a new device that delivers radiation therapy to a specific tumor site at the annual meeting of the Radiological Society of North America (R...

By using the latest advances in sleep science, technology and cold therapy, we can now harness the incredible health - enhancing properties of temperature - regulated sleep therapy that can transform the quality of your sleep and support a healthy body and mind.

A study published in The Journal of Cosmetic and Laser Therapy showed significant improvements in skin appearance after just 12 weeks of sauna skin therapy using near - infrared techTherapy showed significant improvements in skin appearance after just 12 weeks of sauna skin therapy using near - infrared techtherapy using near - infrared technology.

A study published in the Journal of Cosmetic and Laser Therapy ¹ showed significant improvements in skin appearance after just 12 weeks of sauna therapy using near - infrared LED techTherapy ¹ showed significant improvements in skin appearance after just 12 weeks of sauna therapy using near - infrared LED techtherapy using near - infrared LED technology.

With the advent of digital technologies, iLs was launched in 2007 to provide a more affordable and effective therapy (sound combined with visual, vestibular and movement) which could be used in homes and schools as well as clinics.

She's known for her noninvasive approach to anti-aging and uses a range of technologies in her facials like microdermabrasion, oxygen therapy and microcurrent.

Amgen takes a «biology first» approach, using cutting - edge science and technology to study human biological mechanisms in search of therapies for diseases.

Laser therapy uses cutting edge technology to reduce pain and inflammation and to manage certain existing dental problems in animals.

Vet - Stem, a company focused on bringing regenerative medicine technology to veterinarians, has developed a therapy to treat arthritis in dogs using the pet's own fat tissue!

Pulsed Signal Therapy is a relatively new technology used to treat chronic pain in pets.

Our goal is to provide the best veterinary care through the use of modern technology in diagnostics, medical therapies, surgical procedures, and preventative health care.

Stem cell therapy is an emerging medical technology popularly used in the equine industry to treat horses for a variety of athletic injuries.

Our state - of - the - art 6,000 square foot facility uses the latest technology in laser surgery, digital x-ray, ultrasound, low level laser therapy and endoscopy.

As part of that, I have become involved in using new technology to see if cold laser therapy will aid in healing turtles affected by being cold - stunned, when they are exposed to cold water temperatures for a long time, similar to hypothermia.

Elaine now works exclusively in the Physical Therapy and Rehabilitation Department where she uses her combined 25 years experience, veterinary technology degree, and CCRA training to provide exceptional care to her patients.

This along with our utilization of the last technology, which includes: digital radiography (DR system using low dose radiation exposure), ultrasound, full in - house laboratory, endoscope, surgical laser, and cold laser therapy, allows our doctors and staff to provide top - tier patient care.

Staff doubles it as metaphor for the use of certain chemicals in hormone therapy, while vistas of desolate freeways and toxic waste sites flicker in and out; Soshoux appears as an infrared inversion, a swift comment on technology's mercilessness in transforming human beings into anonymous data points.

AGTC plans to use the net proceeds of the offering to fund preclinical investigation and Phase 1/2 trials of potential product candidates for treatment of wet AMD; to expand its manufacturing capabilities and create a pilot manufacturing group; to in - license, acquire or invest in complementary gene therapy, technologies, products or assets; and for working capital and other general corporate purposes.